Prime Medicine, Inc. (NASDAQ: PRME)
$2.9250
-0.2250 ( -5.95% ) 432.6K
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Market Data
Open
$2.9250
Previous close
$3.1500
Volume
432.6K
Market cap
$392.83M
Day range
$2.9000 - $3.1750
52 week range
$2.5600 - $9.7700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 20, 2024 |
8-k | 8K-related | 18 | Feb 16, 2024 |
8-k | 8K-related | 14 | Feb 14, 2024 |
3 | Insider transactions | 2 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
8-k | 8K-related | 43 | Jan 08, 2024 |
8-k | 8K-related | 12 | Jan 05, 2024 |
8-k | 8K-related | 13 | Jan 05, 2024 |